Visiongain publishes Biosensors Market Report 2020-2030

30 April 2020
Pharma

Visiongain has launched a new pharma report Biosensors Market Report 2020-2030: Forecasts by Technology (Thermal, Electrochemical, Optical, Piezoelectric, Application (Medical (Cholesterol, Blood Gas Analyzer, Drug Discovery, Blood Glucose, Pregnancy Testing, Infectious Disease), Food Toxicity, Bioreactor, Agriculture, Environment, Others), End Use (Home Healthcare Diagnostics, PoC Testing, Food Industry, Research Laboratories, Security and Bio-defense), and Geography (North America, Latin America, Europe, Asia Pacific, MEA).

The global biosensors market is anticipated to grow at a lucrative CAGR of xyz% and anticipated to reach USD xyz billion by 2020. Visiongain anticipates that the global biosensors market will grow on account of the emergence of nanotechnology-based biosensors coupled with growing technological advancements in recent years.

To access the data contained in this document please email contactus@visiongain.com

Also, the global market for biosensors will see lucrative growth rates due to the growing applications of biosensors in the medical field. For example, wearable biosensors are of significant interest due to their ability to provide continuous, real-time physiological details by complex, non-invasive measurements of biochemical markers in biofluids such as blood, tears, saliva, and interstitial fluid. The latest innovations have centered on electrochemical and optical biosensors, along with improvements in the non-invasive detection of biomarkers, including metabolites, bacteria, and hormones.

The food producers across the globe are progressively demanding effective quality control methods to meet consumer & regulatory requirements to improve the feasibility of production, quality, automation, & cost and time reduction in production. In general, chemical and microbiological analyzes are performed periodically in the food and agricultural industries by trained operators, which are expensive and require extraction or sample pretreatment steps, thus increasing the analysis time. Biosensor technology can overcome all the inconveniences and offer affordable and fast quality control methods. Considering all these aspects biosensors are anticipated to play a vital role in industrial growth over the forecast period.

North America held the largest market share in the year 2019 owing to the growing prevalence of chronic diseases coupled with a growing preference for wearable biosensors. Also, the market will continue to be driven by the existence of the target population and increased R&D investment by important business organizations. Asia Pacific region is expected to experience the highest growth in terms of CAGR over the forecast period owing to the growing presence of target patient pool in markets such as India and China. Additionally, unmet needs of patients and untapped nations in this region have been attracting investments by global players and this is expected to boost the Biosensors Market growth over the forecast period.

Currently, key players are forming various strategies such as acquisitions, mergers, partnerships, collaborations, and launching new products to strengthen their position in the global biosensors market. Companies are also expanding their R&D, distribution, and management facilities to expand their business and to hold a competitive edge in the Biosensors Market.

The comprehensive market report features companies such as AZUR Environmental, Abbott Laboratories, Biosensor BV, Bayer AG, Cranfield Biotechnology Centre, DuPont Biosensor Materials, EG & IC Sensors Inc., Ercon, Inc., Innovative Biosensors Inc., Johnson & Johnson, LifeScan, Inc., Molecular Devices Corp., Pinnacle Technologies Inc., Sysmex Corporation, QTL Biosystems, Roche Diagnostics among other prominent players. Also the research study offers market estimation and forecast for the period ranging 2020-2030 for global markets such as North America, Latin America, Europe, Asia Pacific and MEA along with regional sub-markets as U.S., Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Russia, India, Japan, China, Australia, ASEAN, GCC and South Africa.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Plasma Therapy Market Report 2021-2031

The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.

26 November 2020

Read

Visiongain Publishes Precision Cancer Diagnostic Test Market Report 2021-2031

Molecular diagnostics are rapidly transforming drug development and patient selection: trials with biomarkers have higher success rates than those without, and combining patients with a proven biomarker allows efficient trials to be conducted in rare cancers.

26 November 2020

Read

Visiongain Publishes Top 50 Biosimilar Drug Manufacturers 2021

Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.

25 November 2020

Read

Visiongain Publishes Advanced Therapy Medicinal Products (ATMP) Market Report 2021-2031

Currently, the ATMP market is at a nascent stage and is expected to flourish during near future owing to increasing research and development activities and rising use of ATMP therapy products in treatment areas with low or no alternative treatment options support the market growth

24 November 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever